Literature DB >> 8232881

SPECT, CT and MRI in a Turkish family with Huntington's disease.

R P Bruyn1, G Hageman, J A Geelen, F A van der Weel, A R Rozeboom, F Barkhof, P Scheltens.   

Abstract

A Turkish family with Huntington's disease documented on CT, MRI and SPECT is reported. Whereas in clinically definite cases CT and MRI are of limited value and SPECT does not add anything of value, in one asymptomatic subject SPECT showed moderate caudate nucleus hypoperfusion, underlining the hypothesis that SPECT may have a role in predicting Huntington's disease.

Entities:  

Mesh：

Year:  1993        PMID： 8232881     DOI： 10.1007/bf00588713

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  18 in total

1.  A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.

Authors:  S T Grafton; J C Mazziotta; J J Pahl; P St George-Hyslop; J L Haines; J Gusella; J M Hoffman; L R Baxter; M E Phelps
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

2.  Single photon emission computed tomography in Huntington's chorea.

Authors:  F Leblhuber; K Hoell; F Reisecker; B Gebetsberger; W Puehringer; E Trenkler; E Deisenhammer
Journal:  Psychiatry Res       Date:  1989-09       Impact factor: 3.222

3.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

4.  Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?

Authors:  C Lang
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

5.  Normal caudate glucose metabolism in persons at risk for Huntington's disease.

Authors:  A B Young; J B Penney; S Starosta-Rubinstein; D Markel; S Berent; J Rothley; A Betley; R Hichwa
Journal:  Arch Neurol       Date:  1987-03

6.  The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease.

Authors:  M R Hayden; J Hewitt; A J Stoessl; C Clark; W Ammann; W R Martin
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

7.  Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.

Authors:  D E Kuhl; M E Phelps; C H Markham; E J Metter; W H Riege; J Winter
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422

8.  Technetium-99m HMPAO imaging in patients with basal ganglia disease.

Authors:  F W Smith; H G Gemmell; P F Sharp; J A Besson
Journal:  Br J Radiol       Date:  1988-10       Impact factor: 3.039

9.  Cerebral metabolism of glucose in benign hereditary chorea.

Authors:  O Suchowersky; M R Hayden; W R Martin; A J Stoessl; A M Hildebrand; B D Pate
Journal:  Mov Disord       Date:  1986       Impact factor: 10.338

10.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.

Authors:  J C Mazziotta; M E Phelps; J J Pahl; S C Huang; L R Baxter; W H Riege; J M Hoffman; D E Kuhl; A B Lanto; J A Wapenski
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245
View more
  1 in total

1.  Huntington's disease: a molecular genetic and CT comparison.

Authors:  P Sharma; L Savy; J Britton; R Taylor; A Howick; M Patton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.